VRTX- Vertex Pharmaceuticals Incorporated

Name: Vertex Pharmaceuticals Incorporated Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 49 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Kewalramani Reshma	133.5K	$60.29M	-
COO	Arbuckle Stuart A	63.4K	$28.62M	-
VP	Wagner Charles F Jr	51.1K	$23.07M	-
VP	Tatsis Ourania	42.3K	$19.10M	-
Other	Leiden Jeffrey M	24.0K	$10.85M	-

Activity

Buys and sells only

Transactions

10 filings · page 19

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 16, 2022	Sanna Bastiano	EVP, Cell &Genetic Therapies	Sell	45	$252.83	$11,377.26	-	+20.2%	+35.8%
May 16, 2022	Arbuckle Stuart A	EVP, COO	Sell	133	$251.19	$33,408.27	-	+20.2%	+35.8%
May 16, 2022	Liu Joy	SVP, General Counsel	Sell	133	$252.88	$33,633.06	-0.2%	+20.2%	+35.8%
May 4, 2022	Sanna Bastiano	EVP, Cell &Genetic Therapies	Sell	36	$275.09	$9,903.24	-	+0.1%	+26.6%
May 2, 2022	Wagner Charles F Jr50	EVP &Chief Financial Officer	Sell	343	$258.83	$88,778.23	-0.1%	+4.5%	+32.1%
May 2, 2022	Sanna Bastiano	EVP, Cell &Genetic Therapies	Sell	320	$259.16	$82,929.73	-0.1%	+4.5%	+32.1%
May 2, 2022	Arbuckle Stuart A	EVP, COO	Sell	306	$263.98	$80,777.88	-0.5%	+4.5%	+32.1%
May 2, 2022	Bhatia Sangeeta N.48	Director	Sell	737	$258.94	$190,842.43	-1.7%	+4.5%	+32.1%
Apr 29, 2022	Liu Joy	SVP, General Counsel	Sell	120	$275.41	$33,048.88	-0.2%	+2.8%	+24.7%
Apr 25, 2022	Ambrose Kristen	SVP &Chief Accounting Officer	Sell	327	$269.55	$88,143.05	-2.2%	+4.4%	+22.2%

← PrevPage 19Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC